ACEs and ARBs Are Similar in Treatment of Proteinuria

Chi Chu, MD, an assistant professor in the division of nephrology at the University of California San Francisco, discusses the similarities and differences of ACEs and ARBs in practice.

In a Pharmacy Times® interview, Chi Chu, MD, an assistant professor in the division of nephrology at the University of California San Francisco, spoke about his 2021 ASN Kidney Week presentation on the submaximal dose of angiotensin converting enzyme (ACE) inhibitor and angiotensin II receptor blockers (ARB) for individuals with proteinuria.

He discussed the similarities and differences of ACEs and ARBs in practice.